New Delhi, Oct. 13 -- The Institute of Liver and Biliary Sciences (ILBS) has tested more than 30,000 blood donor samples through Individual Donor Nucleic Acid Testing (NAT) since introducing the service in January 2024. The facility adds molecular screening capacity to Delhi's public healthcare system.

ILBS said it is currently the only Delhi government hospital conducting Individual Donor-NAT testing. The institute has established a dedicated laboratory intended to serve both its own requirements and the wider network of Delhi government blood centres.

NAT detects genetic material from viruses that can be transmitted through transfusions, including HIV-1, HIV-2, hepatitis B and hepatitis C. Unlike conventional serological testing, whic...